Skip to main content
. 2019 Jan 30;68(11):2044–2056. doi: 10.1136/gutjnl-2018-316091

Figure 2.

Figure 2

Characterisation of human bone marrow mesenchymal stem cell (hBMSC)-derived hepatocytes in hBMSC-Fah-/- Rag2-/- IL-2Rγc-/-SCID (FRGS) mice. (A) Detection of the serum human albumin (hALB) level and percentage of human leucocyte antigen-positive (HLA+) cells in the total population of liver cells (n=8/group). (B) Percentage of hALB+, hNTCP+ and hCD45+ cells in the HLA+ cells from week 0 to 60 after hBMSC transplantation (n=8/group). (C) Correlation analysis between the serum hALB level and the percentage of hNTCP+ cells in the whole population of liver cells collected from hBMSC-FRGS mice (n=8/group). (D) Morphology of fluorescent-activated cell sorting (FACS)-sorted hALB+ hBMSC-hepatocytes (Heps) at week 12 after transplantation (bar=50 µm). (E) Detection of perfused hBMSC-Heps by immunofluorescence (IF) staining for hALB and hNTCP at week 12 after transplantation (bar=50 µm). (F) Quantitative reverse transcription PCR (qRT-PCR) analysis of the expression of 19 hepatic genes in the perfused hBMSC-Heps from week 12 to 60 after transplantation; primary human hepatocytes and hBMSCs were used as controls (n=6/group). (G) Immunohistochemistry (IHC) staining of liver tissues collected from hBMSC-FRGS mice at week 12 after transplantation for human hepatocyte markers, including hALB, hCK18, hAAT, hFAH and hNTCP (bar=100 µm). (H) IHC staining for hALB+ hBMSC-Heps in the whole liver lobe showed multiple distribution patterns, including periportal, non-periportal, scatter-like, island-like and cluster-like patterns (bar=1 mm). hFAH, human hepatocyte-specific fumarate dehydrogenase; hAAT, human hepatocyte-specific alpha-1-antitrypsin; hCK18, human hepatocyte-specific cytokeratin 18; hNTCP, human sodium-sodium taurocholate co-transporting polypeptide.